Schedule 13G ownership disclosure
ASSERTIO THERAPEUTICS INC
Security class unavailable · CUSIP: 04545L107
Event date: 2019-11-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,059,416
- Percent of class
- 5.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-19-062600
- Form type
- SC 13G
- Filer
- Assertio Therapeutics, Inc
- CIK
- CIK 1005201
- Filed
- Nov 12, 2019
- Reporting period
- Nov 01, 2019
- Description
- Schedule 13G beneficial ownership